By Samuel Wells Why did Jesus come? The traditional argument is that he came to redeem us from sin and destroy death, and thus reverse the fall. Many have long found this unsatisfactory, because it centres human deficit, rather than divine abundance. In this study, Samuel Wells traces his notion of ‘being with’ right into the Trinity itself, and in dialogue with Maximus the Confessor, Duns Scotus and Karl Barth, among others, articulates a truly Christocentric theology in which God’s means and God’s ends are identical. In the process, Wells not only greatly expands the compass of ‘being with,’ showing its scriptural and doctrinal significance, but also offers a constructive account of the incarnation, cross and resurrection of Jesus that out-narrates conventional atonement theories. Wells correspondingly proposes an account of sin, evil, suffering and death that accords with this revised understanding. The result is a compelling and transformational proposal in incarnational theology.
Product Details
Publisher : Cambridge University Press
Publication date : January 23, 2025
Language : English
ISBN-10 : 1009492705
ISBN-13 : 978-1009492706

Non-Obstetric Surgery During Pregnancy: A Comprehensive Guide 1st ed. 2019 Edition, Kindle Edition
Pharmacology of Ocular Therapeutics (PDF)
FOR Esthetic Soft Tissue – Inaki Gamborena, Patrick Rutten and Luc Rutten
Cell Reports Medicine – Volume 3, Issue 12 2022 PDF
Lange Q&A Radiography Examination, Tenth Edition
Essentials of Nuclear Medicine Imaging 6th
Stem Cells: New Frontiers in Science & Ethics
Partial Extraction Therapy Course
Ridge Augmentation – Luca De Stavola
Decision Making for Retreatment of Failures in Dental Medicine
Sexually Transmitted Infections: Diagnosis, Management, and Treatment
Mechanical Ventilation in Emergency Medicine
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th Edition
Practical Radiological Anatomy
Teaching Cultural Competence in Nursing and Health Care, Third Edition: Inquiry, Action, and Innovation 


Reviews
There are no reviews yet.